Park Square Executive Search

2016 Search Placements & Industry News

Justin Ehrenwerth Named President and CEO of The Water Institute of the Gulf

The Water Institute of the Gulf announced Wednesday that Justin Ehrenwerth will take the helm as president and CEO starting Jan. 30.

John Caron named associate dean of JHU’s Advanced Academic Programs

John Caron has been named associate dean of the Krieger School of Arts and Sciences Advanced Academic Programs, effective Jan. 1, 2017.

WAVE Life Sciences Appoints Christian Henry to its Board of Directors

WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing targeted therapies for patients impacted by rare diseases, today announced the appointment of Christian Henry, Executive Vice President & Chief Commercial Officer of Illumina, Inc., to its Board of Directors and as the Chair of its Audit Committee.

CeQur® Appoints Robert Farra Chief Executive Officer

CeQur® SA, a leader in simple insulin infusion for people with type 2 diabetes, announced the appointment of Robert Farra as chief executive officer, effective today.

Alzheimer’s Drug Development Company Cognition Therapeutics Appoints Kenneth I. Moch President & CEO

Cognition Therapeutics, Inc., a clinical stage neuroscience therapeutics company, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer of the company. Mr. Moch will also join the company’s Board of Directors.

Robert Arena Named JHU Center for Talented Youth’s New Senior Director of Online Programs

Robert Arena, an online education executive with experience in course development and program marketing, has been named Senior Director of Online Programs at the Johns Hopkins Center for Talented Youth. At CTY, Arena will oversee all aspects of the center’s renowned online education for academically advanced pre-college students.

Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic Development

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that Michael Aldridge has joined the company as Senior Vice President, Corporate & Strategic Development. 

Epizyme Appoints Pamela Strode as Vice President, Regulatory Affairs and Quality Assurance

Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, today announced that it has appointed Pamela Strode to the position of vice president of regulatory affairs and quality assurance. 

Rachel Frick named Executive Director, OCLC Research Library Partnership

OCLC is pleased to announce the appointment of Rachel Frick as Executive Director, OCLC Research Library Partnership.

WAVE Life Sciences Appoints Keith Regnante as Chief Financial Officer

WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing stereopure nucleic acid therapies for patients impacted by rare diseases, today announced that it has appointed Keith Regnante as the company’s Chief Financial Officer. Mr. Regnante will provide strategic direction and bring substantial management experience to WAVE’s finance and operations functions.

ReShape Medical® Announces the Appointment of Michael J. Mangano as President and Chief Executive Officer

ReShape Medical Inc. today announced the appointment of Michael J. Mangano as President and Chief Executive Officer. Mr. Mangano, whose 20 year career in the medical device field has included numerous commercial leadership roles, joins ReShape Medical as the Company marks one year since the U.S. Food and Drug Administration (FDA) approved its ReShape® Dual Balloon. 

Cardiome Announces the Addition of Two Key Members to its Management Team

(Park Square placed Dr. David Palling) 

Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that it has expanded its management team with the addition of Mr. Frank Murphy, who will serve as Cardiome's Vice President of Finance, and Dr. David Palling, who will serve as the company's Vice President of Manufacturing and Supply Chain. 

Paul Bolno, CEO at WAVE and current Park Square client, has been named to PharmaVoice 100

This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. 

Interactions Expands Leadership Team with Appointment of Deepak Batheja as Executive Vice President of Technology and CIO

Interactions, LLC, a leader in speech and natural language technology and developer of Intelligent Virtual Assistant solutions for enterprise customer care, today appointed Deepak Batheja as Executive Vice President of Technology and CIO, further expanding its roster of experienced leadership personnel. Batheja will primarily focus on expanding Interactions’ rich portfolio of customer care offerings, powered by artificial and human intelligence.

MBTA to accept Apple Pay as part of expanded mobile-app rollout

Commuter rail and ferry passengers will be able to pay for tickets with Apple Pay beginning this fall, as part of an expanded mobile ticketing partnership between the Massachusetts Bay Transportation Authority and London-based transportation technology firm Masabi.

Interactions Welcomes Jason Bristow as its new Chief Financial Officer

Interactions, LLC, a leader in speech and natural language technology solutions, today announced the appointment of industry veteran Jason Bristow to its executive leadership team as Chief Financial Officer.

Wellesley College Appoints Nancy Coleman as Associate Provost & Director, Strategic Growth Initiatives

Wellesley College has appointed Nancy Coleman as Associate Provost and Director, Strategic Growth Initiatives. 

Wendi Heinzelman named dean of the Hajim School of Engineering & Applied Sciences

Wendi B. Heinzelman, currently dean of graduate studies for Arts, Sciences, and Engineering (AS&E), and professor of electrical and computer engineering, will be the next dean of the Hajim School of Engineering & Applied Sciences. Heinzelman will be the Hajim School’s first female dean and has been appointed to a five-year term beginning July 1, 2016.

Colt Names Kenji Hioki Chief Revenue Officer Asia / Regional Executive

Colt Technology Services Ltd., announced today that Kenji Hioki has been named Chief Revenue Officer Asia / Regional Executive effective on 1 May 2016. 

Novo Nordisk Appoints Aaron Schwartz as Director, R&D Sourcing

Novo Nordisk has appointed Aaron Schwartz as Director, R&D Sourcing. Schwartz joins Novo Nordisk from the MIT Technology Licensing Office where he spent over a decade in various roles of increasing responsibility including: Technology Licensing Officer; Associate Technology Licensing Officer; and Technology Licensing Associate. Prior, Schwartz served as a Business Development and Strategy Consultant at Akceli, Inc. His earlier career was spent as an Analyst at Mercer Management Consulting. 

Margaret Levenstein named director of ISR Inter-university Consortium for Political and Social Research

Margaret Levenstein has been appointed the director of the Inter-University Consortium for Political and Social Research at the U-M Institute for Social Research. 

Deciphera Pharmaceuticals Appoints David Brooks, M.D., Ph.D. as Vice President, Clinical Development & Translational Medicine

Deciphera Pharmaceuticals has appointed David Brooks as Vice President, Clinical Development & Translational Medicine. 

Alice Li will direct Cornell’s technology transfer group

Alice Li, Ph.D. ’98, has been named executive director of Cornell’s Center for Technology Licensing (CTL), the university’s patent and technology transfer arm. She had been serving as the group’s interim director since August 2014.

FLX Bio Completes Leadership Team in Immuno-Oncology Drug Discovery

FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, announced today that it has appointed Rekha Hemrajani as Chief Operating Officer. 

DePaul University names composer, community engagement leader as dean for School of Music

DePaul University has selected Dr. Ronald Caltabiano, an internationally recognized composer with more than 25 years of experience in higher education, as the next dean for the School of Music​, effective July 1.

Rice economist Antonio Merlo named dean of Rice’s School of Social Sciences

Antonio Merlo, the George A. Peterkin Professor and department chair of economics at Rice University, has been appointed dean of Rice’s School of Social Sciences. The appointment is effective July 1. 

Poxel Appoints Jonae R. Barnes as Senior Vice President Investor Relations and Public Relations, based in Boston

Poxel SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced that Jonae R. Barnes has joined the Company as Senior Vice President, Investor Relations and Public Relations. Ms. Barnes will be based in the Boston area, a leading area in drug development and innovation.

Nanotechnology expert selected to lead OHSU’s large-scale early cancer detection initiative

Sadik Esener, Ph.D., will help launch the OHSU Knight Cancer Institute’s recruitment of 20 to 30 top scientists and their research teams. 

Mathai Mammen, The Anti-Shkreli, Brings Heart And A Touch Of Vagelos To Merck R&D

Park Square client, Mathai Mammen of Theravance Biopharma, will join Merck this spring to lead a significant portion of the company’s discovery research organization. Mammen founded Theravance in 1996 and has served as Senior Vice President of R&D.

Mary McKernan McKay named Brown School dean

Mary McKernan McKay, the McSilver Professor of Poverty Studies and director of the McSilver Institute for Poverty Policy and Research at New York University’s Silver School of Social Work, has been appointed dean of the Brown School at Washington University in St. Louis, effective July 1, according to Chancellor Mark S. Wrighton.

Karoly Mirnics, M.D., Ph.D., is new director of MMI

Following a nationwide search, Karoly Mirnics, M.D., Ph.D., has accepted the position of director of the Munroe-Meyer Institute for Genetics and Rehabilitation.

Nanocomp Technologies, Inc. Appoints Paul Hallee as Chief Financial Officer

Nanocomp Technologies, Inc. has appointed Paul Hallee as Chief Financial Officer. Hallee most recently served at Sand 9, Inc. as Chief Financial Officer.

Theravance Biopharma Appoints Richard Graham as Senior Director, Clinical Pharmacology

Theravance Biopharma has appointed Richard Graham as Senior Director, Clinical Pharmacology. Graham joins Theravance from Onyx Pharmaceuticals, where he served as Senior Director, Head of Clinical Pharmacology. 

Aldeyra Therapeutics Appoints David J. Clark, M.D. as Chief Medical Officer

Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that David J. Clark, M.D. has joined the Company as its Chief Medical Officer, effective January 11, 2016.